Award

Delivery Order #SPE2DR26F7WM3

Short-Term Delivery Order Contract for Ondansetron HCL to Federal Agency

Buyer

Defense Logistics Agency

Award Amount

$848.62

Ceiling

$848.62

Awarded

March 11, 2026

Period of Performance

Mar 11, 2026 – Mar 12, 2026

Identifier

SPE2DR26F7WM3

NAICS

424210

This award represents a delivery order contract under an existing indefinite delivery vehicle (IDV) contract with AmerisourceBergen Drug Corp, a leading pharmaceutical distributor known for supplying essential medications. The contract is for the procurement of Ondansetron HCL 8 mg tablets, a drug commonly used to prevent nausea and vomiting caused by chemotherapy or surgery. This short-term, multi-day contract supports the agency's ongoing healthcare efforts by ensuring timely access to critical pharmaceuticals. The delivery order was competitively issued under the IDV framework, which was previously awarded for pharmaceutical product procurement, emphasizing efficient and reliable medication supply. The contract's limited duration and focused scope highlight its role in addressing specific, immediate treatment needs within the federal healthcare delivery system.

Description

4571117373!ONDANSETRON HCL 8 MG TABLET UD 100S

View original record